v3.26.1
Share-Based Compensation
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation Share-Based Compensation
The Company has issued non-qualified stock option awards to management, other key employees, consultants, and non-employee directors and these options ratably vest over a four-year service period. In addition, we issued options in connection with the private placement on February 27, 2024, that vest ratably over a three-year period. The option awards expire after a term of ten years from the date of grant. As of March 31, 2026, the Company had total unrecognized stock-based compensation expense for its outstanding stock option awards of approximately $13.4 million, which is expected to be recognized over a weighted average period of 3.2 years. The weighted average grant date fair value of options granted during the three months ended March 31, 2026, and 2025 was $28.56 and $14.97 per option, respectively. The aggregate intrinsic value of the in-the-money awards outstanding at March 31, 2026, was de minimis.
The following table summarizes the activity related to the stock option awards for the three months ended March 31, 2026:
Number of Shares Weighted
Average Exercise Price
Aggregate Intrinsic Value (in thousands)
Awards outstanding at December 31, 20251,017,620 $25.18 
Granted475,719 37.04 
Awards outstanding at March 31, 20261,493,339 $28.96 $20,731 
Options exercisable at March 31, 2026520,306 $31.51 $8,947 
Weighted average remaining contractual term7.1 Years
Options vested and expected to vest at March 31, 20261,208,395 $28.50 
Weighted average remaining contractual term8.3 Years
Compensation expense related to the grants of stock options is included in research and development and general and administrative expense as follows (in thousands):
Three Months Ended March 31,
20262025
Research and development$444 $227 
General and administrative944 586 
Total share-based compensation expense$1,388 $813